VG Life Sciences, Inc. Issues Audit Update and Future Intentions
New York, NY (December 11, 2024) VG Life Sciences, Inc. (“VGLS” or the “Company”), has released a statement to update shareholders on the Company’s audit.
In a statement released today, the Company is confirming that the Company’s auditor, Fruci & Associates, will complete the 2023 audit prior to the end of December 2024. It is the intent of the Company and its auditor to then quickly complete the 2024 audit.
Subsequent to the completion of both the 2023 and 2024 audits, the Company will file a Form 10 registration statement to once again become a fully reporting Company.
After the Form 10 is effective, it is the Company’s intent to complete a transaction that will deliver value to shareholders.
About the Company
VG Life Sciences, Inc. (OTCBB: VGLS) is a holding company.
Safe Harbor
This release contains statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements appear in a number of places in this release and include all statements that are not statements of historical fact regarding the intent, belief or current expectations of the Company, its directors or its officers with respect to, among other things: (i) financing plans; (ii) trends affecting its financial condition or results of operations; (iii) growth strategy and operating strategy. The words "may," "would," "will," "expect," "estimate," "can," "believe," "potential" and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. More information about the potential factors that could affect the business and financial results is and will be included in the Company’s filings with the Securities and Exchange Commission and/or OTC Markets.
Press Contact Details:
+1 (424) 224-5358
info@vglscorp.com